Fundraising Fox
Pilatus Biosciences
1 known investors
Find your way into Pilatus Biosciences
Sign up to see every warm intro you have to Pilatus Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pilatus Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pilatus Biosciences develops first-in-class antibodies and bifunctional proteins that target metabolic checkpoints to reprogram the immune microenvironment for treating cancer and immune-related diseases. Its lead candidate, an anti-CD36 monoclonal antibody, is in Phase 1 clinical trials for advanced solid tumors.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Pilatus Biosciences do?
- Pilatus Biosciences develops first-in-class antibodies and bifunctional proteins that target metabolic checkpoints to reprogram the immune microenvironment for treating cancer and immune-related diseases. Its lead candidate, an anti-CD36 monoclonal antibody, is in Phase 1 clinical trials for advanced solid tumors.
- Who founded Pilatus Biosciences?
- Pilatus Biosciences was founded by Raven Lin.
- Who are Pilatus Biosciences's investors?
- Pilatus Biosciences's investors include Mosaic Venture Lab.